Related Experiment Video
Updated: Jan 15, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
Assessment of Neuromuscular Blockade Depth Using Train-of-Four (TOF) Monitoring Following Rocuronium Extravasation
Keitaro Yoshioka1, Tsuwa Iwamoto1, Hirokazu Kawase1
1Department of Anesthesiology, Toho University Omori Medical Center, Tokyo, JPN.
Abstract:
This report describes a case of accidental rocuronium extravasation in a patient with end-stage renal disease. We were unable to assess the depth of neuromuscular blockade due to fluctuating train-of-four (TOF) counts ranging from 0 to 4 between 37 and 90 minutes post-first rocuronium administration. However, the first twitch height in TOF stimulation (T1) was persistently low during this period and appeared to reflect a deep level of neuromuscular blockade. Thereafter, T1 increased steadily in response to rising TOF count and TOF ratio. In our case, T1 was low on average during TOF count fluctuation, at 2 ± 2% (mean ± standard deviation). Between 91 and 105 minutes post-first rocuronium administration, TOF counts of 4 were observed more frequently, and the mean T1 increased to 7 ± 4%. Beginning at 106 minutes post-first rocuronium administration, the TOF count remained constant at 4, and the mean T1 increased to 9 ± 3%. Beginning at 135 minutes, the TOF ratio appeared to be constant, and the mean T1 increased to 18 ± 5% until 162 minutes. At 185 minutes post-first rocuronium administration, we administered sugammadex 200 mg (3.17 mg/kg) after the patient's breathing had recovered spontaneously (end-tidal CO₂ was 42 mmHg, tidal volume exceeded 6 mL/kg, and respiratory rate was 12 breaths/min). The patient experienced no adverse events such as postoperative recurarization. In our case, although the TOF count was unstable, T1 appeared to reliably reflect changes in the depth of neuromuscular blockade.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Therapeutic Uses

